Regulation of catalase expression in healthy and cancerous cells

Free Radical Biology and Medicine

Volumn 87, Issue , 2015, Pages 84-97

  Glorieux, Christophe ^a   Zamocky, Marcel ^b,c   Sandoval, Juan Marcelo ^a   Verrax, Julien ^a   Calderon, Pedro Buc ^a,d  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d UNIVERSIDAD ARTURO PRAT   (Chile)

Author keywords

Cancer; Catalase; Catalase promoter; Freeradicals; Transcriptionfactors; Transcriptionregulation

Indexed keywords

BINDING PROTEIN; CATALASE; HUMORAL ANTIBODY; NUCLEAR FACTOR Y; ORGANIC CATION TRANSPORTER 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR SP1; ANTIOXIDANT; DNA BINDING PROTEIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CANCER CELL; DNA BINDING; ENZYME REGULATION; EPIGENETICS; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; BINDING SITE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY;

ANTIOXIDANTS; BINDING SITES; CATALASE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84938217134     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.06.017     Document Type: Review

References (211)

1. P. Wieacker, C.R. Mueller, A. Mayerova, K.H. Grzeschik, and H.H. Ropers Assignment of the gene coding for human catalase to the short arm of chromosome 11 Ann. Genet. 23 1980 73 77
2. F. Quan, R.G. Korneluk, M.B. Tropak, and R.A. Gravel Isolation and characterization of the human catalase gene Nucleic Acids Res. 14 1986 5321 5335
3. O. Loew A new enzyme of general occurrence in organisms Science 11 1900 701 702
4. R.A. Nagem, E.A. Martins, V.M. Goncalves, R. Aparicio, and I. Polikarpov Crystallization and preliminary X-ray diffraction studies of human catalase Acta Crystallogr. D Biol. Crystallogr 55 1999 1614 1615
5. M. Zamocky, P.G. Furtmuller, and C. Obinger Evolution of catalases from bacteria to humans Antioxid. Redox Signaling 10 2008 1527 1548
6. L. Gebicka, and J. Didik Catalytic scavenging of peroxynitrite by catalase J. Inorg. Biochem. 103 2009 1375 1379
7. S. Heinzelmann, and G. Bauer Multiple protective functions of catalase against intercellular apoptosis-inducing ROS signaling of human tumor cells Biol. Chem. 391 2010 675 693
8. Y. Kono, T. Yamasaki, A. Ueda, and H. Shibata Catalase catalyzes of peroxynitrite-mediated phenolic nitration Biosci. Biotechnol. Biochem. 62 1998 448 452
9. L. Brunelli, V. Yermilov, and J.S. Beckman Modulation of catalase peroxidatic and catalatic activity by nitric oxide Free Radic. Biol. Med. 30 2001 709 714
10. L.H. Johansson, and L.A. Borg A spectrophotometric method for determination of catalase activity in small tissue samples Anal. Biochem. 174 1988 331 336
11. A.M. Vetrano, D.E. Heck, T.M. Mariano, V. Mishin, D.L. Laskin, and J.D. Laskin Characterization of the oxidase activity in mammalian catalase J. Biol. Chem. 280 2005 35372 35381
12. M. Nishikawa, M. Hashida, and Y. Takakura Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis Adv. Drug Delivery Rev 61 2009 319 326
13. M.C. Winternitz, and C.R. Meloy On the occurrence of catalase in human tissues and its variations in diseases J. Exp. Med. 10 1908 759 781
14. 2-removing enzyme in human erythrocytes Blood 90 1997 4973 4978
15. S.R. Terlecky, J.I. Koepke, and P.A. Walton Peroxisomes and aging Biochim. Biophys. Acta 1763 2006 1749 1754
16. J.F. Thomson, and F.J. Klipfel Further studies on cytoplasmic particulates isolated by gradient centrifugation Arch. Biochem. Biophys. 70 1957 224 238
17. E. Middelkoop, E.A. Wiemer, D.E. Schoenmaker, A. Strijland, and J.M. Tager Topology of catalase assembly in human skin fibroblasts Biochim. Biophys. Acta 1220 1993 15 20
18. R.J. Wanders, A. Strijland, C.W. van Roermund, H. Van den Bosch, R.B. Schutgens, J.M. Tager, and et al. Catalase in cultured skin fibroblasts from patients with the cerebro-hepato-renal (Zellweger) syndrome: normal maturation in peroxisome-deficient cells Biochim. Biophys. Acta 923 1987 478 482
19. R. Radi, J.F. Turrens, L.Y. Chang, K.M. Bush, J.D. Crapo, and B.A. Freeman Detection of catalase in rat heart mitochondria J. Biol. Chem. 266 1991 22028 22034
20. G. Bauer Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling Anticancer Res. 32 2012 2599 2624
21. L. Goth, P. Rass, and A. Pay Catalase enzyme mutations and their association with diseases Mol. Diagn. 8 2004 141 149
22. J. Kodydkova, L. Vavrova, M. Kocik, and A. Zak Human catalase, its polymorphisms, regulation and changes of its activity in different diseases Folia Biol. (Praha) 60 2014 153 167
23. A.M. Baker, L.W. Oberley, and M.B. Cohen Expression of antioxidant enzymes in human prostatic adenocarcinoma Prostate 32 1997 229 233
24. D.G. Bostwick, E.E. Alexander, R. Singh, A. Shan, J. Qian, R.M. Santella, and et al. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer Cancer 89 2000 123 134
25. H.J. Chung-man, S. Zheng, S.A. Comhair, and C. Farver Erzurum S.C. Differential expression of manganese superoxide dismutase and catalase in lung cancer Cancer Res. 61 2001 8578 8585
26. D.B. Coursin, H.P. Cihla, J. Sempf, T.D. Oberley, and L.W. Oberley An immunohistochemical analysis of antioxidant and glutathione S-transferase enzyme levels in normal and neoplastic human lung Histol. Histopathol. 11 1996 851 860
27. J.J. Cullen, F.A. Mitros, and L.W. Oberley Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer Pancreas 26 2003 23 27
28. G. Guner, H. Islekel, O. Oto, E. Hazan, and U. Acikel Evaluation of some antioxidant enzymes in lung carcinoma tissue Cancer Lett. 103 1996 233 239
29. K.A. Kwei, J.S. Finch, E.J. Thompson, and G.T. Bowden Transcriptional repression of catalase in mouse skin tumor progression Neoplasia 6 2004 440 448
30. C. Lauer, A. Volkl, S. Riedl, H.D. Fahimi, and K. Beier Impairment of peroxisomal biogenesis in human colon carcinoma Carcinogenesis 20 1999 985 989
31. S.L. Marklund, N.G. Westman, E. Lundgren, and G. Roos Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues Cancer Res. 42 1982 1955 1961
32. T.D. Oberley, J.M. Sempf, and L.W. Oberley Immunogold analysis of antioxidant enzymes in common renal cancers Histol. Histopathol. 11 1996 153 160
33. K. Sato, K. Ito, H. Kohara, Y. Yamaguchi, K. Adachi, and H. Endo Negative regulation of catalase gene expression in hepatoma cells Mol. Cell. Biol. 12 1992 2525 2533
34. R. Subapriya, R. Kumaraguruparan, C.R. Ramachandran, and S. Nagini Oxidant-antioxidant status in patients with oral squamous cell carcinomas at different intraoral sites Clin. Biochem. 35 2002 489 493
35. D.G. Yoo, Y.J. Song, E.J. Cho, S.K. Lee, J.B. Park, J.H. Yu, and et al. Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems Lung Cancer 60 2008 277 284
36. 2 levels, and its mechanism of action to induce growth in breast cancer cells: important roles of bioactive catalase and PP2A Free Radic. Biol. Med. 53 2012 1541 1551
37. D. Wu, and P. Yotnda Production and detection of reactive oxygen species (ROS) in cancers. J. Visualized Exp 57 2011 3357
38. W.S. Wu The signaling mechanism of ROS in tumor progression Cancer Metastasis Rev. 25 2006 695 705
39. R. Beck, R.C. Pedrosa, N. Dejeans, C. Glorieux, P. Leveque, B. Gallez, and et al. Ascorbate/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl: an in vitro and in vivo mechanistic study Invest. New Drugs 29 2011 891 900
40. J. Verrax, R.C. Pedrosa, R. Beck, N. Dejeans, H. Taper, and P. Buc Calderon In situ modulation of oxidative stress: a novel and efficient strategy to kill cancer cells Curr. Med. Chem. 16 2009 1821 1830
41. Y. Sun, N.H. Colburn, and L.W. Oberley Depression of catalase gene expression after immortalization and transformation of mouse liver cells Carcinogenesis 14 1993 1505 1510
42. E. Rohrdanz, and R. Kahl Alterations of antioxidant enzyme expression in response to hydrogen peroxide Free Radic. Biol. Med. 24 1998 27 38
43. E. Rohrdanz, G. Schmuck, S. Ohler, and R. Kahl The influence of oxidative stress on catalase and MnSOD gene transcription in astrocytes Brain Res. 900 2001 128 136
44. 2 exposures protects fibroblasts from subsequent stress-induced apoptosis Mutat. Res. 529 2003 87 94
45. Y.Y. Chuang, Y. Chen, Chandramouli V.R. Gadisetti, J.A. Cook, D. Coffin, and et al. Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells Cancer Res. 62 2002 6246 6254
46. 2 J. Biol. Chem. 279 2004 31157 31163
47. V.D. Nair, T. Yuen, C.W. Olanow, and S.C. Sealfon Early single cell bifurcation of pro- and antiapoptotic states during oxidative stress J. Biol. Chem. 279 2004 27494 27501
48. K. Kahlos, Y. Soini, R. Sormunen, R. Kaarteenaho-Wiik, P. Paakko, K. Linnainmaa, and et al. Expression and prognostic significance of catalase in malignant mesothelioma Cancer 91 2001 1349 1357
49. P.S. Smith, W. Zhao, D.R. Spitz, and M.E. Robbins Inhibiting catalase activity sensitizes 36B10 rat glioma cells to oxidative stress Free Radic. Biol. Med. 42 2007 787 797
50. T.S. Hwang, H.K. Choi, and H.S. Han Differential expression of manganese superoxide dismutase, copper/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa Eur. J. Surg. Oncol. 33 2007 474 479
51. T. Rainis, I. Maor, A. Lanir, S. Shnizer, and A. Lavy Enhanced oxidative stress and leucocyte activation in neoplastic tissues of the colon Dig. Dis. Sci. 52 2007 526 530
52. C.S. Sander, F. Hamm, P. Elsner, and J.J. Thiele Oxidative stress in malignant melanoma and non-melanoma skin cancer Br. J. Dermatol. 148 2003 913 922
53. I. Zelen, P. Djurdjevic, S. Popovic, M. Stojanovic, V. Jakovljevic, S. Radivojevic, and et al. Antioxidant enzymes activities and plasma levels of oxidative stress markers in B-chronic lymphocytic leukemia patients J. BUON 15 2010 330 336
54. I. Kasugai, and M. Yamada High production of catalase in hydrogen peroxide-resistant human leukemia HL-60 cell lines Leuk. Res. 16 1992 173 179
55. M. Nenoi, S. Ichimura, K. Mita, O. Yukawa, and I.L. Cartwright Regulation of the catalase gene promoter by Sp1, CCAAT-recognizing factors, and a WT1/Egr-related factor in hydrogen peroxide-resistant HP100 cells Cancer Res. 61 2001 5885 5894
56. M. Yamada, K. Hashinaka, J. Inazawa, and T. Abe Expression of catalase and myeloperoxidase genes in hydrogen peroxide-resistant HL-60 cells DNA Cell Biol. 10 1991 735 742
57. H. Xu, S.M. Choi, C.S. An, Y.D. Min, K.C. Kim, K.J. Kim, and et al. Concentration-dependent collateral sensitivity of cisplatin-resistant gastric cancer cell sublines Biochem. Biophys. Res. Commun. 328 2005 618 622
58. C. Klingelhoeffer, U. Kammerer, M. Koospal, B. Muhling, M. Schneider, M. Kapp, and et al. Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress BMC Complement. Alternat. Med 12 2012 61
59. H.C. Yen, S.H. Li, H.J. Majima, Y.H. Huang, C.P. Chen, C.C. Liu, and et al. Up-regulation of antioxidant enzymes and coenzyme Q(10) in a human oral cancer cell line with acquired bleomycin resistance Free Radic. Res. 45 2011 707 716
60. Y. Kuramitsu, K. Taba, S. Ryozawa, K. Yoshida, X. Zhang, T. Tanaka, and et al. Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry Anticancer Res. 30 2010 3367 3372
61. B.H. Xu, V. Gupta, and S.V. Singh Characterization of a human bladder cancer cell line selected for resistance to mitomycin C Int. J. Cancer 58 1994 686 692
62. Y. Suzuki, Y. Kondo, S. Himeno, K. Nemoto, M. Akimoto, and N. Imura Role of antioxidant systems in human androgen-independent prostate cancer cells Prostate 43 2000 144 149
63. H.C. Lee, D.W. Kim, K.Y. Jung, I.C. Park, M.J. Park, M.S. Kim, and et al. Increased expression of antioxidant enzymes in radioresistant variant from U251 human glioblastoma cell line Int. J. Mol. Med. 13 2004 883 887
64. L. Goth, and A. Shemirani Kalmar T. A novel catalase mutation (a GA insertion) causes the Hungarian type of acatalasemia Blood Cells Mol. Dis. 26 2000 151 154
65. A. Hirono, F. Sasaya-Hamada, H. Kanno, H. Fujii, T. Yoshida, and S. Miwa A novel human catalase mutation (358 T - >del) causing Japanese-type acatalasemia Blood Cells Mol. Dis. 21 1995 232 234
66. J.K. Wen, T. Osumi, T. Hashimoto, and M. Ogata Molecular analysis of human acatalasemia: identification of a splicing mutation J. Mol. Biol. 211 1990 383 393
67. Z. Jiang, J.M. Akey, J. Shi, M. Xiong, Y. Wang, Y. Shen, and et al. A polymorphism in the promoter region of catalase is associated with blood pressure levels Hum. Genet. 109 2001 95 98
68. S. Takahara Progressive oral gangrene probably due to lack of catalase in the blood (acatalasaemia); report of nine cases Lancet 2 1952 1101 1104
69. X.F. Zhou, J. Cui, A.L. DeStefano, I. Chazaro, L.A. Farrer, A.J. Manolis, and et al. Polymorphisms in the promoter region of catalase gene and essential hypertension Dis. Markers 21 2005 3 7
70. Y.S. Ho, Y. Xiong, W. Ma, A. Spector, and D.S. Ho Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury J. Biol. Chem. 279 2004 32804 32812
71. S.E. Schriner, N.J. Linford, G.M. Martin, P. Treuting, C.E. Ogburn, M. Emond, and et al. Extension of murine life span by overexpression of catalase targeted to mitochondria Science 308 2005 1909 1911
72. S. Yano, N. Arroyo, and N. Yano SHP2 binds catalase and acquires a hydrogen peroxide-resistant phosphatase activity via integrin-signaling FEBS Lett. 577 2004 327 332
73. S. Yano, N. Arroyo, and N. Yano Catalase binds Grb2 in tumor cells when stimulated with serum or ligands for integrin receptors Free Radic. Biol. Med. 36 2004 1542 1554
74. C. Glorieux, N. Dejeans, B. Sid, R. Beck, P. Buc Calderon, and J. Verrax Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy Biochem. Pharmacol. 82 2011 1384 1390
75. 2-dependent Snail signaling Free Radic. Biol. Med. 53 2012 44 50
76. M.H. Shah, G.S. Liu, E.W. Thompson, G.J. Dusting, and H.M. Peshavariya Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells Breast Cancer Res. Treat. 150 2015 523 534
77. W.S. Wu, R.K. Tsai, C.H. Chang, S. Wang, J.R. Wu, and Y.X. Chang Reactive oxygen species mediated sustained activation of protein kinase C alpha and extracellular signal-regulated kinase for migration of human hepatoma cell Hepg2 Mol. Cancer Res. 4 2006 747 758
78. D.E. Heck, M. Shakarjian, H.D. Kim, J.D. Laskin, and A.M. Vetrano Mechanisms of oxidant generation by catalase Ann. N. Y. Acad. Sci. 1203 2010 120 125
79. M.W. Epperly, J.A. Melendez, X. Zhang, S. Nie, L. Pearce, J. Peterson, and et al. Mitochondrial targeting of a catalase transgene product by plasmid liposomes increases radioresistance in vitro and in vivo Radiat. Res. 171 2009 588 595
80. H.R. Rezvani, C. Ged, B. Bouadjar, H. de Verneuil, and A. Taieb Catalase overexpression reduces UVB-induced apoptosis in a human xeroderma pigmentosum reconstructed epidermis Cancer Gene Ther 15 2008 241 251
81. T.P. Szatrowski, and C.F. Nathan Production of large amounts of hydrogen peroxide by human tumor cells Cancer Res. 51 1991 794 798
82. Y. Hu, D.G. Rosen, Y. Zhou, L. Feng, G. Yang, J. Liu, and et al. Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress J. Biol. Chem. 280 2005 39485 39492
83. T.D. Oberley, and L.W. Oberley Antioxidant enzyme levels in cancer Histol. Histopathol. 12 1997 525 535
84. A. Glasauer, and N.S. Chandel Targeting antioxidants for cancer therapy Biochem. Pharmacol. 92 2014 90 101
85. D. Trachootham, J. Alexandre, and P. Huang Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discovery 8 2009 579 591
86. J. Verrax, R. Beck, N. Dejeans, C. Glorieux, B. Sid, R.C. Pedrosa, and et al. Redox-active quinones and ascorbate: an innovative cancer therapy that exploits the vulnerability of cancer cells to oxidative stress Anticancer Agents Med. Chem 11 2011 213 221
87. G.T. Wondrak Redox-directed cancer therapeutics: molecular mechanisms and opportunities Antioxid. Redox Signaling 11 2009 3013 3069
88. M. Alfonso-Prieto, X. Biarnes, P. Vidossich, and C. Rovira The molecular mechanism of the catalase reaction J. Am. Chem. Soc. 131 2009 11751 11761
89. H.N. Kirkman, M. Rolfo, A.M. Ferraris, and G.F. Gaetani Mechanisms of protection of catalase by NADPH: kinetics and stoichiometry J. Biol. Chem. 274 1999 13908 13914
90. C.D. Putnam, A.S. Arvai, Y. Bourne, and J.A. Tainer Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism J. Mol. Biol. 296 2000 295 309
91. M. Zamocky, and F. Koller Understanding the structure and function of catalases: clues from molecular evolution and in vitro mutagenesis Prog. Biophys. Mol. Biol. 72 1999 19 66
92. M. Zamocky, P.G. Furtmuller, and C. Obinger Evolution of structure and function of Class I peroxidases Arch. Biochem. Biophys. 500 2010 45 57
93. H. Nakashima, M. Yamamoto, K. Goto, T. Osumi, T. Hashimoto, and H. Endo Isolation and characterization of the rat catalase-encoding gene Gene 89 1990 295
94. D.L. Reimer, J. Bailley, and S.M. Singh Complete cDNA and 5′ genomic sequences and multilevel regulation of the mouse catalase gene. Genomics 21 1994 325 336
95. L. Li, C.M. Artlett, S.A. Jimenez, D.J. Hall, and J. Varga Positive regulation of human alpha 1 (I) collagen promoter activity by transcription factor Sp1 Gene 164 1995 229 234
96. K.C. Brown, H.E. Perry, J.K. Lau, D.V. Jones, J.F. Pulliam, B.A. Thornhill, and et al. Nicotine induces the up-regulation of the alpha7-nicotinic receptor (alpha7-nAChR) in human squamous cell lung cancer cells via the Sp1/GATA protein pathway J. Biol. Chem. 288 2013 33049 33059
97. X. Zhu, Y. Wang, W. Pi, H. Liu, A. Wickrema, and D. Tuan NF-Y recruits both transcription activator and repressor to modulate tissue- and developmental stage-specific expression of human gamma-globin gene PLoS One 7 2012 e47175
98. J. Gilthorpe, M. Vandromme, T. Brend, A. Gutman, D. Summerbell, N. Totty, and et al. Spatially specific expression of Hoxb4 is dependent on the ubiquitous transcription factor NFY Development 129 2002 3887 3899
99. R. Huber, D. Schlessinger, and G. Pilia Multiple Sp1 sites efficiently drive transcription of the TATA-less promoter of the human glypican 3 (GPC3) gene Gene 214 1998 35 44
100. D.P. Singh, B. Bhargavan, B. Chhunchha, E. Kubo, A. Kumar, and N. Fatma Transcriptional protein Sp1 regulates LEDGF transcription by directly interacting with its cis-elements in GC-rich region of TATA-less gene promoter PLoS One 7 2012 e37012
101. R. Xu, P. Zhang, J. Huang, S. Ge, J. Lu, and G. Qian Sp1 and Sp3 regulate basal transcription of the survivin gene Biochem. Biophys. Res. Commun. 356 2007 286 292
102. J.H. Yoo, S.C. Erzurum, J.G. Hay, P. Lemarchand, and R.G. Crystal Vulnerability of the human airway epithelium to hyperoxia: constitutive expression of the catalase gene in human bronchial epithelial cells despite oxidant stress J. Clin. Invest. 93 1994 297 302
103. S.L. Ackerman, A.G. Minden, G.T. Williams, C. Bobonis, and C.Y. Yeung Functional significance of an overlapping consensus binding motif for Sp1 and Zif268 in the murine adenosine deaminase gene promoter Proc. Natl. Acad. Sci. USA 88 1991 7523 7527
104. D. Luo, and T.A. Rando The regulation of catalase gene expression in mouse muscle cells is dependent on the CCAAT-binding factor NF-Y Biochem. Biophys. Res. Commun. 303 2003 609 618
105. Y. Liu, M. Adachi, S. Zhao, M. Hareyama, A.C. Koong, D. Luo, and et al. Preventing oxidative stress: a new role for XBP1 Cell Death Differ. 16 2009 847 857
106. H. Yoshida, T. Matsui, A. Yamamoto, T. Okada, and K. Mori XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor Cell 107 2001 881 891
107. Y. Zhong, J. Li, J.J. Wang, C. Chen, J.T. Tran, A. Saadi, and et al. X-box binding protein 1 is essential for the anti-oxidant defense and cell survival in the retinal pigment epithelium PLoS One 7 2012 e38616
108. Y. Liu, X. Zhang, Y. Liang, H. Yu, X. Chen, T. Zheng, and et al. Targeting X box-binding protein-1 (XBP1) enhances sensitivity of glioma cells to oxidative stress Neuropathol. Appl. Neurobiol. 37 2011 395 405
109. J. Lu, D.M. Wu, Y.L. Zheng, B. Hu, W. Cheng, Z.F. Zhang, and et al. Troxerutin counteracts domoic acid-induced memory deficits in mice by inhibiting CCAAT/enhancer binding protein beta-mediated inflammatory response and oxidative stress J. Immunol. 190 2013 3466 3479
110. M. Taniguchi, M. Hashimoto, N. Hori, and K. Sato CCAAT/enhancer binding protein-beta (C/EBP-beta), a pivotal regulator of the TATA-less promoter in the rat catalase gene FEBS Lett. 579 2005 5785 5790
111. H. Toda, T. Takeuchi, N. Hori, K. Ito, and K. Sato Inverted repeats in the TATA-less promoter of the rat catalase gene J. Biochem. 121 1997 1035 1040
112. G. Tzivion, M. Dobson, and G. Ramakrishnan FoxO transcription factors: regulation by AKT and 14-3-3 proteins Biochim. Biophys. Acta 1813 2011 1938 1945
113. G. Rena, S. Guo, S.C. Cichy, T.G. Unterman, and P. Cohen Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B J. Biol. Chem. 274 1999 17179 17183
114. L.P. Van Der Heide, M.F. Hoekman, and M.P. Smidt The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation Biochem. J. 380 2004 297 309
115. G.J. Kops, T.B. Dansen, P.E. Polderman, I. Saarloos, K.W. Wirtz, P.J. Coffer, and et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress Nature 419 2002 316 321
116. S. Ramaswamy, N. Nakamura, I. Sansal, L. Bergeron, and W.R. Sellers A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR Cancer Cell 2 2002 81 91
117. H. Tran, A. Brunet, J.M. Grenier, S.R. Datta, A.J. Fornace Jr., P.S. DiStefano, and et al. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296 2002 530 534
118. W.Q. Tan, K. Wang, D.Y. Lv, and P.F. Li Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase J. Biol. Chem. 283 2008 29730 29739
119. M. Li, J.F. Chiu, J. Gagne, and N.K. Fukagawa Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells J. Cell. Physiol. 217 2008 377 387
120. C. Glorieux, J. Auquier, N. Dejeans, B. Sid, J.B. Demoulin, L. Bertrand, and et al. Catalase expression in MCF-7 breast cancer cells is mainly controlled by PI3K/Akt/mTor signaling pathway Biochem. Pharmacol. 89 2014 217 223
121. A. Brunet, A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, L.S. Hu, and et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 96 1999 857 868
122. G.J. Brunn, J. Williams, C. Sabers, G. Wiederrecht, J.C. Lawrence Jr., and R.T. Abraham Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002 EMBO J. 15 1996 5256 5267
123. H. Akca, A. Demiray, M. Aslan, I. Acikbas, and O. Tokgun Tumour suppressor PTEN enhanced enzyme activity of GPx, SOD and catalase by suppression of PI3K/AKT pathway in non-small cell lung cancer cell lines J. Enzyme Inhib. Med. Chem 28 2013 539 544
124. S. Kim, S.H. Lee, S. Kang, L. Lee, J.D. Park, and D.Y. Ryu Involvement of c-Met- and phosphatidylinositol 3-kinase dependent pathways in arsenite-induced downregulation of catalase in hepatoma cells Biol. Pharm. Bull. 34 2011 1748 1752
125. H. Liang, and W.F. Ward PGC-1alpha: a key regulator of energy metabolism Adv. Physiol. Educ. 30 2006 145 151
126. J. St-Pierre, S. Drori, M. Uldry, J.M. Silvaggi, J. Rhee, S. Jager, and et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators Cell 127 2006 397 408
127. Y. Olmos, I. Valle, S. Borniquel, A. Tierrez, E. Soria, S. Lamas, and et al. Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes J. Biol. Chem. 284 2009 14476 14484
128. M. Roth, and W.Y. Chen Sorting out functions of sirtuins in cancer Oncogene 33 2014 1609 1620
129. Y. Olmos, F.J. Sanchez-Gomez, B. Wild, N. Garcia-Quintans, S. Cabezudo, S. Lamas, and et al. SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1alpha complex Antioxid. Redox Signaling 19 2013 1507 1521
130. S. Nemoto, M.M. Fergusson, and T. Finkel SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha} J. Biol. Chem. 280 2005 16456 16460
131. N. Ferrara, B. Rinaldi, G. Corbi, V. Conti, P. Stiuso, S. Boccuti, and et al. Exercise training promotes SIRT1 activity in aged rats Rejuvenation Res 11 2008 139 150
132. K. Hasegawa, S. Wakino, K. Yoshioka, S. Tatematsu, Y. Hara, H. Minakuchi, and et al. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression Biochem. Biophys. Res. Commun. 372 2008 51 56
133. H.J. Park, J.R. Carr, Z. Wang, V. Nogueira, N. Hay, A.L. Tyner, and et al. FoxM1, a critical regulator of oxidative stress during oncogenesis EMBO J. 28 2009 2908 2918
134. S. Xiong, G. Salazar, M.A. San, M. Ahmad, N. Patrushev, L. Hilenski, and et al. PGC-1 alpha serine 570 phosphorylation and GCN5-mediated acetylation by angiotensin II drive catalase down-regulation and vascular hypertrophy J. Biol. Chem. 285 2010 2474 2487
135. B. Venkatesan, L. Mahimainathan, F. Das, N. Ghosh-Choudhury, and C.G. Ghosh Downregulation of catalase by reactive oxygen species via PI 3 kinase/Akt signaling in mesangial cells J. Cell. Physiol. 211 2007 457 467
136. J. Berger, and D.E. Moller The mechanisms of action of PPARs Annu. Rev. Med. 53 2002 409 435
137. J.N. Feige, L. Gelman, L. Michalik, B. Desvergne, and W. Wahli From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions Prog. Lipid Res. 45 2006 120 159
138. S.A. Kliewer, H.E. Xu, M.H. Lambert, and T.M. Willson Peroxisome proliferator-activated receptors: from genes to physiology Recent Prog. Horm. Res. 56 2001 239 263
139. Y. Okuno, M. Matsuda, Y. Miyata, A. Fukuhara, R. Komuro, M. Shimabukuro, and et al. Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse Endocr. J. 57 2010 303 309
140. G.D. Girnun, F.E. Domann, S.A. Moore, and M.E. Robbins Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter Mol. Endocrinol. 16 2002 2793 2801
141. Y. Okuno, M. Matsuda, H. Kobayashi, K. Morita, E. Suzuki, A. Fukuhara, and et al. Adipose expression of catalase is regulated via a novel remote PPARγ-responsive region Biochem. Biophys. Res. Commun. 366 2008 698 704
142. A. Bernardo, D. Bianchi, V. Magnaghi, and L. Minghetti Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells J. Neuropathol. Exp. Neurol. 68 2009 797 808
143. T. Chen, X. Jin, B.H. Crawford, H. Cheng, T.B. Saafir, M.B. Wagner, and et al. Cardioprotection from oxidative stress in the newborn heart by activation of PPARγ is mediated by catalase Free Radic. Biol. Med. 53 2012 208 215
144. N.K. Khoo, S. Hebbar, W. Zhao, S.A. Moore, F.E. Domann, and M.E. Robbins Differential activation of catalase expression and activity by PPAR agonists: implications for astrocyte protection in anti-glioma therapy Redox Biol 1 2013 70 79
145. W. Yang, J. Zhang, H. Wang, W. Shen, P. Gao, M. Singh, and et al. Peroxisome proliferator-activated receptor gamma regulates angiotensin II-induced catalase downregulation in adventitial fibroblasts of rats FEBS Lett. 585 2011 761 766
146. X. Zhao, R. Strong, J. Zhang, G. Sun, J.Z. Tsien, Z. Cui, and et al. Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia J. Neurosci. 29 2009 6186 6195
147. E. Flori, A. Mastrofrancesco, D. Kovacs, Y. Ramot, S. Briganti, B. Bellei, and et al. 2,4,6-Octatrienoic acid is a novel promoter of melanogenesis and antioxidant defence in normal human melanocytes via PPAR-gamma activation Pigment Cell Melanoma Res. 24 2011 618 630
148. E. Yakunin, H. Kisos, W. Kulik, J. Grigoletto, R.J. Wanders, and R. Sharon The regulation of catalase activity by PPAR gamma is affected by alpha-synuclein Ann. Clin. Transl. Neurol 1 2014 145 159
149. E. Gray, M. Ginty, K. Kemp, N. Scolding, and A. Wilkins The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function J. Neuroinflammation 9 2012 63
150. D. Bishop-Bailey, and T. Hla Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2 J. Biol. Chem. 274 1999 17042 17048
151. S. Goetze, F. Eilers, A. Bungenstock, U. Kintscher, P. Stawowy, F. Blaschke, and et al. PPAR activators inhibit endothelial cell migration by targeting Akt Biochem. Biophys. Res. Commun. 293 2002 1431 1437
152. B. Farrow, and B.M. Evers Activation of PPARγ increases PTEN expression in pancreatic cancer cells Biochem. Biophys. Res. Commun. 301 2003 50 503
153. Y. Kitagishi, and S. Matsuda Diets involved in PPAR and PI3K/AKT/PTEN pathway may contribute to neuroprotection in a traumatic brain injury Alzheimers Res. Ther 5 2013 42
154. D. Tantin, C. Schild-Poulter, V. Wang, R.J. Hache, and P.A. Sharp The octamer binding transcription factor Oct-1 is a stress sensor Cancer Res. 65 2005 10750 10758
155. X. Quan, S.O. Lim, and G. Jung Reactive oxygen species downregulate catalase expression via methylation of a CpG island in the Oct-1 promoter FEBS Lett. 585 2011 3436 3441
156. R. Venugopal, and Jaiswal A.K. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes Oncogene 17 1998 3145 3156
157. H. Zhu, K. Itoh, M. Yamamoto, J.L. Zweier, and Y. Li Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury FEBS Lett. 579 2005 3029 3036
158. H. Zhu, Z. Jia, L. Zhang, M. Yamamoto, H.P. Misra, M.A. Trush, and et al. Antioxidants and phase 2 enzymes in macrophages: regulation by Nrf2 signaling and protection against oxidative and electrophilic stress Exp. Biol. Med. (Maywood) 233 2008 463 474
159. H. Zhu, Z. Jia, B.R. Misra, L. Zhang, Z. Cao, M. Yamamoto, and et al. Nuclear factor E2-related factor 2-dependent myocardiac cytoprotection against oxidative and electrophilic stress Cardiovasc. Toxicol. 8 2008 71 85
160. K.M. Fong, P.V. Zimmerman, and P.J. Smith Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer Genes Chromosomes Cancer 10 1994 183 189
161. E. Toska, and S.G. Roberts Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1) Biochem. J. 461 2014 15 32
162. J.C. Reddy, and J.D. Licht The WT1 Wilms' tumor suppressor gene: how much do we really know? Biochim. Biophys. Acta 1287 1996 1 28
163. I.A. Drummond, H.D. Rupprecht, P. Rohwer-Nutter, J.M. Lopez-Guisa, S.L. Madden, F.J. Rauscher III, and et al. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1 Mol. Cell. Biol. 14 1994 3800 3809
164. S.B. Lee, and D.A. Haber Wilms tumor and the WT1 gene Exp. Cell Res. 264 2001 74 99
165. H. Nakagama, G. Heinrich, J. Pelletier, and D.E. Housman Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product Mol. Cell. Biol. 15 1995 1489 1498
166. T. Takeuchi, S. Nakamura, A. Kayasuga, S. Isa, and K. Sato Multiple elements for negative regulation of the rat catalase gene expression in dedifferentiated hepatoma cells J. Biochem. 128 2000 1025 1031
167. J.P. Greenstein The in vivo effect on liver catalase by a tumor J. Natl. Cancer Inst. 15 1955 1603 1605
168. T. Higashi, K. Kashiwagi, and K. Warabioka Catalase of tumor-bearing animals. I. Combined immunochemical and enzymic determination of catalase in liver cell fractions Gann 59 1968 461 466
169. Y. Yamaguchi, K. Sato, and H. Endo Depression of catalase gene expression in the liver of tumor bearing nude mice Biochem. Biophys. Res. Commun. 189 1992 1084 1089
170. Z. Zhu, S. Mukhina, T. Zhu, H.C. Mertani, K.O. Lee, and P.E. Lobie p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis Oncogene 24 2005 3774 3785
171. J.A. Mobley, and R.W. Brueggemeier Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer Carcinogenesis 25 2004 3 9
172. E. Petit, A. Courtin, H.J. Kloosterboer, W. Rostene, P. Forgez, and A. Gompel Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition J. Steroid Biochem. Mol. Biol. 115 2009 153 160
173. C. Michaeloudes, M.B. Sukkar, N.M. Khorasani, P.K. Bhavsar, and K.F. Chung TGF-beta regulates Nox4, MnSOD and catalase expression, and IL-6 release in airway smooth muscle cells Am. J. Physiol. Lung Cell. Mol. Physiol. 300 2011 L295 L304
174. C.U. Ludwig, G. Raefle, P. Dalquen, P. Stulz, R. Stahel, and J.P. Obrecht Allelic loss on the short arm of chromosome 11 in non-small-cell lung cancer Int. J. Cancer 49 1991 661 665
175. R. Shipman, P. Schraml, M. Colombi, and C.U. Ludwig Allelic deletion at chromosome 11p13 defines a tumour suppressor region between the catalase gene and D11S935 in human non-small cell lung carcinoma Int. J. Oncol. 12 1998 107 111
176. C. Barletta, M.A. Castello, E. Ferrante, I. Mavelli, A. Clerico, M.R. Ciriolo, and et al. 11p13 deletion and reduced RBC catalase in a patient with aniridia, glaucoma and bilateral Wilms' tumor Tumori 71 1985 119 121
177. J.L. Dufier, L.H. Phug, P. Schmelck, C. Fekete, J. de Grouchy, C. Turleau, and et al. [Intercalary deletion of the short arm of chromosome 11: aniridia, glaucoma, staturoponderal and mental retardation, sexual ambiguity, gonadoblastoma and catalase deficiency] Bull. Soc. Ophtalmol. Fr 81 1981 747 749
178. M.J. Gregoire, C. Pernot, F. Himont, M. Pierson, and S. Gilgenkrantz [Chromosome 11 and cancer] J. Genet. Hum 31 1983 31 36
179. E.E. Michalopoulos, P.J. Bevilacqua, N. Stokoe, V.E. Powers, H.F. Willard, and W.H. Lewis Molecular analysis of gene deletion in aniridia-Wilms tumor association Hum. Genet. 70 1985 157 162
180. L. Sabatier, F. Hoffschir, W.A. al Achkar, C. Turleau, J. de Grouchy, and B. Dutrillaux The decrease of catalase or esterase D activity in patients with microdeletions of 11p or 13q does not increase their radiosensitivity Ann. Genet. 32 1989 144 148
181. E.N. Sotnikova, L.A. Durnov, R.V. Zhordania, R.F. Gar'kavtseva, and A.F. Bukhny [Changes in the hemoglobin fractions of nephroblastoma patients] Genetika 20 1984 357 361
182. V. van Heyningen, P.A. Boyd, A. Seawright, J.M. Fletcher, J.A. Fantes, K.E. Buckton, and et al. Molecular analysis of chromosome 11 deletions in aniridia-Wilms tumor syndrome Proc. Natl. Acad. Sci. USA 82 1985 8592 8596
183. F. Hoffschir, M. Vuillaume, L. Sabatier, M. Ricoul, L. Daya-Grosjean, S. Estrade, and et al. Decrease in catalase activity and loss of the 11p chromosome arm in the course of SV40 transformation of human fibroblasts Carcinogenesis 14 1993 1569 1572
184. A. Matsui, T. Ihara, H. Suda, H. Mikami, and K. Semba Gene amplification: mechanisms and involvement in cancer Biomol. Concepts 4 2013 567 582
185. C.R. Hunt, J.E. Sim, S.J. Sullivan, T. Featherstone, W. Golden, C. Von Kapp-Herr, and et al. Genomic instability and catalase gene amplification induced by chronic exposure to oxidative stress Cancer Res. 58 1998 3986 3992
186. L. Forsberg, L. Lyrenas, U. de Faire, and R. Morgenstern A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels Free Radic. Biol. Med. 30 2001 500 505
187. S. Ezzikouri, A.E. El Feydi, R. Afifi, M. Benazzouz, M. Hassar, P. Pineau, and et al. Polymorphisms in antioxidant defence genes and susceptibility to hepatocellular carcinoma in a Moroccan population Free Radic. Res. 44 2010 208 216
188. J. Ahn, M.D. Gammon, R.M. Santella, M.M. Gaudet, J.A. Britton, S.L. Teitelbaum, and et al. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use Am. J. Epidemiol. 162 2005 943 952
189. R. Nadif, S.R. Kleeberger, and F. Re Kauffmann "Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use." Am. J. Epidemiol. 163 2006 874 875
190. C.L. Smith, and G.L. Hager Transcriptional regulation of mammalian genes in vivo: a tale of two templates J. Biol. Chem. 272 1997 27493 27496
191. M. Tsompana, and M.J. Buck Chromatin accessibility: a window into the genome Epigenet. Chromatin 7 2014 33
192. T.B. Lee, Y.S. Moon, and C.H. Choi Histone H4 deacetylation down-regulates catalase gene expression in doxorubicin-resistant AML subline Cell Biol. Toxicol. 28 2012 11 18
193. J.Y. Min, S.O. Lim, and G. Jung Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter FEBS Lett. 584 2010 2427 2432
194. S. Ding, B.D. Gong, J. Yu, J. Gu, H.Y. Zhang, Z.B. Shang, and et al. Methylation profile of the promoter CpG islands of 14 "drug-resistance" genes in hepatocellular carcinoma World J. Gastroenterol. 10 2004 3433 3440
195. S. Ribieras, X.G. Song-Wang, V. Martin, P. Lointier, L. Frappart, and R. Dante Human breast and colon cancers exhibit alterations of DNA methylation patterns at several DNA segments on chromosomes 11p and 17p J. Cell. Biochem. 56 1994 86 96
196. S.A. Akman, G. Forrest, F.F. Chu, and J.H. Doroshow Resistance to hydrogen peroxide associated with altered catalase mRNA stability in MCF7 breast cancer cells Biochim. Biophys. Acta 1009 1989 70 74
197. B. Ghosh, E. Barbosa, and I. Singh Characterization of fibroblast cytoplasmic proteins that bind to the 3′ UTR of human catalase mRNA Mol. Cell. Biochem. 209 2000 9 15
198. D. Sampath, and R. Perez-Polo Regulation of antioxidant enzyme expression by NGF Neurochem. Res. 22 1997 351 362
199. D. Yu, C.O. dos Santos, G. Zhao, J. Jiang, J.D. Amigo, E. Khandros, and et al. miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta Genes Dev. 24 2010 1620 1633
200. R. Haque, E. Chun, J.C. Howell, T. Sengupta, D. Chen, and H. Kim MicroRNA-30b-mediated regulation of catalase expression in human ARPE-19 cells PLoS One 7 2012 e42542
201. K. Uenoyama, and T. Ono Post-transcriptional regulation of catalase synthesis in rat liver and hepatoma: binding of inhibiting factor(s) with polyribosomes synthesizing catalase J. Mol. Biol. 74 1973 453 466
202. C. Cao, Y. Leng, and D. Kufe Catalase activity is regulated by c-Abl and Arg in the oxidative stress response J. Biol. Chem. 278 2003 29667 29675
203. C. Cao, Y. Leng, X. Liu, Y. Yi, P. Li, and D. Kufe Catalase is regulated by ubiquitination and proteosomal degradation: role of the c-Abl and Arg tyrosine kinases Biochemistry 42 2003 10348 10353
204. R. Rafikov, S. Kumar, S. Aggarwal, Y. Hou, A. Kangath, D. Pardo, and et al. Endothelin-1 stimulates catalase activity through the PKCδ-mediated phosphorylation of serine 167 Free Radic. Biol. Med. 67 2014 255 264
205. H. Yan, and J.J. Harding Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase Biochem. J. 328 1997 599 605
206. H. Furuta, A. Hachimori, Y. Ota, and T. Samejima Dissociation of bovine liver catalase into subunits on acetylation J. Biochem. 76 1974 481 491
207. M.Y. Kang, H.B. Kim, C. Piao, K.H. Lee, J.W. Hyun, I.Y. Chang, and et al. The critical role of catalase in prooxidant and antioxidant function of p53 Cell Death Differ. 20 2013 117 129
208. D. Watters, P. Kedar, K. Spring, J. Bjorkman, P. Chen, M. Gatei, and et al. Localization of a portion of extranuclear ATM to peroxisomes J. Biol. Chem. 274 1999 34277 34282
209. J. LoPiccolo, G.M. Blumenthal, W.B. Bernstein, and P.A. Dennis Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updates 11 2008 32 50
210. J. Rodon, R. Dienstmann, V. Serra, and J. Tabernero Development of PI3K inhibitors: lessons learned from early clinical trials Nat. Rev. Clin. Oncol. 10 2013 143 153
211. X.Z. Ding, M.S. Talamonti, R.H. Bell Jr., and T.E. Adrian A novel anti-pancreatic cancer agent, LY293111 Anticancer Drugs 16 2005 467 473